Literature DB >> 29380126

The new TNM-based staging of breast cancer.

Gábor Cserni1,2, Ewa Chmielik3, Bálint Cserni4, Tibor Tot5.   

Abstract

This review describes the changes that have been implemented in the Tumor-Node-Metastasis (TNM)-based staging of breast cancers by the new, 8th editions of the relevant Union for International Cancer Control (UICC) and American Joint Committee on Cancer (AJCC) publications. After giving a background for TNM being the common language of cancer staging and related activities like cancer treatment and registration, it summarizes not only the changes but reviews some highlights important for pathologists, and lists and comments on the differences between the publications and diagnostic practices based on them. A section is dedicated to the prognostic stages of breast carcinomas introduced in the AJCC Cancer Staging Manual, but not mentioned in the UICC TNM classification of malignant tumors. A few issues that are not appropriately covered by TNM according to the authors' view (e.g., multifocal tumors, larger lymph node metastases identified by molecular methods, the heterogeneous prognosis of M1-defined stage IV disease) close the review with the final thoughts raising the vision of a potential loss of the common staging language.

Entities:  

Keywords:  Breast cancer; TNM staging

Mesh:

Year:  2018        PMID: 29380126     DOI: 10.1007/s00428-018-2301-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  26 in total

Review 1.  Intraoperative analysis of sentinel lymph nodes in breast cancer by one-step nucleic acid amplification.

Authors:  Gábor Cserni
Journal:  J Clin Pathol       Date:  2011-11-16       Impact factor: 3.411

2.  The use of Vernier scales.

Authors:  D W Cotton; N Kirkham
Journal:  Histopathology       Date:  1991-12       Impact factor: 5.087

Review 3.  Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.

Authors:  Shona Hendry; Roberto Salgado; Thomas Gevaert; Prudence A Russell; Tom John; Bibhusal Thapa; Michael Christie; Koen van de Vijver; M V Estrada; Paula I Gonzalez-Ericsson; Melinda Sanders; Benjamin Solomon; Cinzia Solinas; Gert G G M Van den Eynden; Yves Allory; Matthias Preusser; Johannes Hainfellner; Giancarlo Pruneri; Andrea Vingiani; Sandra Demaria; Fraser Symmans; Paolo Nuciforo; Laura Comerma; E A Thompson; Sunil Lakhani; Seong-Rim Kim; Stuart Schnitt; Cecile Colpaert; Christos Sotiriou; Stefan J Scherer; Michail Ignatiadis; Sunil Badve; Robert H Pierce; Giuseppe Viale; Nicolas Sirtaine; Frederique Penault-Llorca; Tomohagu Sugie; Susan Fineberg; Soonmyung Paik; Ashok Srinivasan; Andrea Richardson; Yihong Wang; Ewa Chmielik; Jane Brock; Douglas B Johnson; Justin Balko; Stephan Wienert; Veerle Bossuyt; Stefan Michiels; Nils Ternes; Nicole Burchardi; Stephen J Luen; Peter Savas; Frederick Klauschen; Peter H Watson; Brad H Nelson; Carmen Criscitiello; Sandra O'Toole; Denis Larsimont; Roland de Wind; Giuseppe Curigliano; Fabrice André; Magali Lacroix-Triki; Mark van de Vijver; Federico Rojo; Giuseppe Floris; Shahinaz Bedri; Joseph Sparano; David Rimm; Torsten Nielsen; Zuzana Kos; Stephen Hewitt; Baljit Singh; Gelareh Farshid; Sibylle Loibl; Kimberly H Allison; Nadine Tung; Sylvia Adams; Karen Willard-Gallo; Hugo M Horlings; Leena Gandhi; Andre Moreira; Fred Hirsch; Maria V Dieci; Maria Urbanowicz; Iva Brcic; Konstanty Korski; Fabien Gaire; Hartmut Koeppen; Amy Lo; Jennifer Giltnane; Marlon C Rebelatto; Keith E Steele; Jiping Zha; Kenneth Emancipator; Jonathan W Juco; Carsten Denkert; Jorge Reis-Filho; Sherene Loi; Stephen B Fox
Journal:  Adv Anat Pathol       Date:  2017-09       Impact factor: 3.875

4.  Breast cancer multifocality, disease extent, and survival.

Authors:  Tibor Tot; Mária Gere; Gyula Pekár; Miklós Tarján; Syster Hofmeyer; Dan Hellberg; David Lindquist; Tony Hsiu-His Chen; Amy Ming-Fang Yen; Sherry Yueh-Hsia Chiu; László Tabár
Journal:  Hum Pathol       Date:  2011-06-12       Impact factor: 3.466

Review 5.  Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis.

Authors:  Francisco E Vera-Badillo; Marc Napoleone; Alberto Ocana; Arnoud J Templeton; Bostjan Seruga; Mustafa Al-Mubarak; Hashem AlHashem; Ian F Tannock; Eitan Amir
Journal:  Breast Cancer Res Treat       Date:  2014-06-14       Impact factor: 4.872

6.  The natural history of breast carcinoma: what have we learned from screening?

Authors:  L Tabár; S W Duffy; B Vitak; H H Chen; T C Prevost
Journal:  Cancer       Date:  1999-08-01       Impact factor: 6.860

Review 7.  Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM).

Authors:  M J Duffy; N Harbeck; M Nap; R Molina; A Nicolini; E Senkus; F Cardoso
Journal:  Eur J Cancer       Date:  2017-02-28       Impact factor: 9.162

8.  Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful?

Authors:  Isabelle de Mascarel; Gaetan MacGrogan; Marc Debled; Veronique Brouste; Louis Mauriac
Journal:  Cancer       Date:  2008-04-15       Impact factor: 6.860

9.  Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

Authors:  W Fraser Symmans; Florentia Peintinger; Christos Hatzis; Radhika Rajan; Henry Kuerer; Vicente Valero; Lina Assad; Anna Poniecka; Bryan Hennessy; Marjorie Green; Aman U Buzdar; S Eva Singletary; Gabriel N Hortobagyi; Lajos Pusztai
Journal:  J Clin Oncol       Date:  2007-09-04       Impact factor: 44.544

10.  Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review.

Authors:  Umar Wazir; Ali Wazir; Clive Wells; Kefah Mokbel
Journal:  Oncol Lett       Date:  2016-11-01       Impact factor: 2.967

View more
  48 in total

1.  Analysis of membranous Ki-67 staining in breast cancer and surrounding breast epithelium.

Authors:  Gábor Cserni
Journal:  Virchows Arch       Date:  2018-03-28       Impact factor: 4.064

2.  Impact of biomarkers and genetic profiling on breast cancer prognostication: A comparative analysis of the 8th edition of breast cancer staging system.

Authors:  Esther C Yoon; Christopher Schwartz; Edi Brogi; Katia Ventura; Hannah Wen; Farbod Darvishian
Journal:  Breast J       Date:  2019-06-13       Impact factor: 2.431

3.  The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements.

Authors:  Pınar Borman; Ayşegül Yaman; Lütfi Doğan; Ayşe Arıkan Dönmez; Esra Gizem Koyuncu; Ayşegül Balcan; Sercan Aksoy; Cihangir Özaslan; Rabiye Akın; Kaniye Üneş
Journal:  Eur J Breast Health       Date:  2022-04-01

4.  The subgross morphology of breast carcinomas: a single-institution series of 2033 consecutive cases documented in large-format histology slides.

Authors:  Tibor Tot; Maria Gere; Syster Hofmeyer; Annette Bauer; Ulrika Pellas
Journal:  Virchows Arch       Date:  2019-08-13       Impact factor: 4.064

5.  Relationship between Ribosomal Protein S6-pS240 Expression and other Prognostic Factors in Non-Special Type Invasive Breast Cancer.

Authors:  Frederik Cuperjani; Lumturije Gashi; Fisnik Kurshumliu; Shemsedin Dreshaj; Fitim Selimi
Journal:  Breast Care (Basel)       Date:  2018-11-14       Impact factor: 2.860

6.  Correlation of microRNA-367 in the clinicopathologic features and prognosis of breast cancer patients.

Authors:  Binghui Liu; Juhua Pan; Chenglin Fu
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

7.  Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer.

Authors:  Koji Takada; Shinichiro Kashiwagi; Yuka Asano; Wataru Goto; Rika Kouhashi; Akimichi Yabumoto; Sae Ishihara; Tamami Morisaki; Masatsune Shibutani; Hiroaki Tanaka; Kosei Hirakawa; Masaichi Ohira
Journal:  BMC Womens Health       Date:  2021-05-29       Impact factor: 2.809

8.  dNLR and TILS can be used as indicators for prognosis and efficacy evaluation of neo-adjuvant chemotherapy in breast cancer.

Authors:  Xiaorui Wang; Weipeng Zhao; Lihong He; Shuling Wang; Weidong Li; Jing Wang; Zhongsheng Tong
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

9.  First Evidence for a Role of Siglec-8 in Breast Cancer.

Authors:  Anna Trebo; Nina Ditsch; Tom Degenhardt; Christina Kuhn; Martina Rahmeh; Elisa Schmoeckel; Doris Mayr; Bastian Czogalla; Thomas Kolben; Sarah Meister; Sven Mahner; Udo Jeschke; Anna Hester
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

Review 10.  Histological type and typing of breast carcinomas and the WHO classification changes over time.

Authors:  Gábor Cserni
Journal:  Pathologica       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.